• Adams, P.D., Afonine, P.V., Bunkoczi, G., Chen, V.B., Davis, I.W., Echols, N., Headd, J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W., Mccoy, A.J., Moriarty, N.W., Oeffner, R., Read, R.J., Richardson, D.C., Richardson, J.S., Terwilliger, T.C.,Zwart, P.H., 2010. PHENIX:a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr, 66, 213-221.

  • Afonine, P.V., Grosse-Kunstleve, R.W., Echols, N., Headd, J.J., Moriarty, N.W., Mustyakimov, M., Terwilliger, T.C., Urzhumtsev, A., Zwart, P.H.,Adams, P.D., 2012. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr, 68, 352-367.

  • Ahmed, S.M., Hall, A.J., Robinson, A.E., Verhoef, L., Premkumar, P., Parashar, U.D., Koopmans, M.,Lopman, B.A., 2014. Global prevalence of norovirus in cases of gastroenteritis:a systematic review and meta-analysis. The Lancet Infectious Diseases, 14, 725-730.

  • Ao, Y., Cong, X., Jin, M., Sun, X., Wei, X., Wang, J., Zhang, Q., Song, J., Yu, J., Cui, J., Qi, J., Tan, M.,Duan, Z., 2018. Genetic Analysis of Reemerging GII.P16-GII.2 Noroviruses in 2016-2017 in China. J Infect Dis, 218, 133-143.

  • Ao, Y., Wang, J., Ling, H., He, Y., Dong, X., Wang, X., Peng, J., Zhang, H., Jin, M.,Duan, Z., 2017. Norovirus GII.P16/GII.2-Associated Gastroenteritis, China, 2016. Emerging Infectious Diseases, 23, 1172-1175.

  • Cao, S., Lou, Z., Tan, M., Chen, Y., Liu, Y., Zhang, Z., Zhang, X.C., Jiang, X., Li, X.,Rao, Z., 2007. Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol, 81, 5949-5957.

  • Chan, M.C., Lee, N., Hung, T.N., Kwok, K., Cheung, K., Tin, E.K., Lai, R.W., Nelson, E.A., Leung, T.F.,Chan, P.K., 2015. Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014. Nat Commun, 6, 10061.

  • Chen, Y., Tan, M., Xia, M., Hao, N., Zhang, X.C., Huang, P., Jiang, X., Li, X.,Rao, Z., 2011. Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathog, 7, e1002152.

  • Chhabra, P., De Graaf, M., Parra, G.I., Chan, M.C., Green, K., Martella, V., Wang, Q., White, P.A., Katayama, K., Vennema, H., Koopmans, M.P.G.,Vinje, J., 2019. Updated classification of norovirus genogroups and genotypes. J Gen Virol, 100, 1393-1406.

  • Cong, X., Sun, X.M., Qi, J.X., Li, H.B., Chai, W.G., Zhang, Q., Wang, H., Kong, X.Y., Song, J., Pang, L.L., Jin, M., Li, D.D., Tan, M.,Duan, Z.J., 2019. GII.13/21 Noroviruses Recognize Glycans with a Terminal beta-Galactose via an Unconventional Glycan Binding Site. J Virol, 93.

  • De Rougemont, A., Ruvoen-Clouet, N., Simon, B., Estienney, M., Elie-Caille, C., Aho, S., Pothier, P., Le Pendu, J., Boireau, W.,Belliot, G., 2011. Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. J Virol, 85, 4057-4070.

  • Frenck, R., Bernstein, D.I., Xia, M., Huang, P., Zhong, W., Parker, S., Dickey, M., Mcneal, M.,Jiang, X., 2012. Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. J Infect Dis, 206, 1386-1393.

  • Huang, P., Farkas, T., Zhong, W., Tan, M., Thornton, S., Morrow, A.L.,Jiang, X., 2005. Norovirus and histo-blood group antigens:demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol, 79, 6714-6722.

  • Huo, Y., Zheng, L., Chen, X., Ge, L.,Wang, Y., 2017. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China. Microb Pathog, 105, 131-137.

  • Jin, M., Wu, S., Kong, X., Xie, H., Fu, J., He, Y., Feng, W., Liu, N., Li, J., Rainey, J.J., Hall, A.J., Vinje, J.,Duan, Z., 2020. Norovirus Outbreak Surveillance, China, 2016-2018. Emerg Infect Dis, 26, 437-445.

  • Jin, M., Zhou, Y.K., Xie, H.P., Fu, J.G., He, Y.Q., Zhang, S., Jing, H.B., Kong, X.Y., Sun, X.M., Li, H.Y., Zhang, Q., Li, K., Zhang, Y.J., Zhou, D.Q., Xing, W.J., Liao, Q.H., Liu, N., Yu, H.J., Jiang, X., Tan, M.,Duan, Z.J., 2016. Characterization of the new GII.17 norovirus variant that emerged recently as the predominant strain in China. J Gen Virol, 97, 2620-2632.

  • Le Pendu, J., 2004. Histo-blood group antigen and human milk oligosaccharides:genetic polymorphism and risk of infectious diseases. Adv Exp Med Biol, 554, 135-143.

  • Leshem, E., Wikswo, M., Barclay, L., Brandt, E., Storm, W., Salehi, E., Desalvo, T., Davis, T., Saupe, A., Dobbins, G., Booth, H.A., Biggs, C., Garman, K., Woron, A.M., Parashar, U.D., Vinje, J.,Hall, A.J., 2013. Effects and clinical significance of GII.4 Sydney norovirus, United States, 2012-2013. Emerg Infect Dis, 19, 1231-1238.

  • Lindesmith, L., Moe, C., Marionneau, S., Ruvoen, N., Jiang, X., Lindblad, L., Stewart, P., Lependu, J.,Baric, R., 2003. Human susceptibility and resistance to Norwalk virus infection. Nat Med, 9, 548-553.

  • Morozov, V., Hanisch, F.G., Wegner, K.M.,Schroten, H., 2018. Pandemic GII.4 Sydney and Epidemic GII.17 Kawasaki308 Noroviruses Display Distinct Specificities for Histo-Blood Group Antigens Leading to Different Transmission Vector Dynamics in Pacific Oysters. Front Microbiol, 9, 2826.

  • Qian, Y., Song, M., Jiang, X., Xia, M., Meller, J., Tan, M., Chen, Y., Li, X.,Rao, Z., 2019. Structural Adaptations of Norovirus GII.17/13/21 Lineage through Two Distinct Evolutionary Paths. J Virol, 93.

  • Rydell, G.E., Nilsson, J., Rodriguez-Diaz, J., Ruvoen-Clouet, N., Svensson, L., Le Pendu, J.,Larson, G., 2009. Human noroviruses recognize sialyl Lewis x neoglycoprotein. Glycobiology, 19, 309-320.

  • Singh, B.K., Leuthold, M.M.,Hansman, G.S., 2016. Structural Constraints on Human Norovirus Binding to Histo-Blood Group Antigens. mSphere, 1.

  • Song, C., Takai-Todaka, R., Miki, M., Haga, K., Fujimoto, A., Ishiyama, R., Oikawa, K., Yokoyama, M., Miyazaki, N., Iwasaki, K., Murakami, K., Katayama, K.,Murata, K., 2020. Dynamic rotation of the protruding domain enhances the infectivity of norovirus. PLoS Pathog, 16, e1008619.

  • Storry, J.R.,Olsson, M.L., 2009. The ABO blood group system revisited:a review and update. Immunohematology, 25, 48-59.

  • Sun, C., Schattgen, S.A., Pisitkun, P., Jorgensen, J.P., Hilterbrand, A.T., Wang, L.J., West, J.A., Hansen, K., Horan, K.A., Jakobsen, M.R., O'hare, P., Adler, H., Sun, R., Ploegh, H.L., Damania, B., Upton, J.W., Fitzgerald, K.A.,Paludan, S.R., 2015. Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection. J Immunol, 194, 1819-1831.

  • Sun, X., Li, D., Peng, R., Guo, N., Jin, M., Zhou, Y., Xie, G., Pang, L., Zhang, Q., Qi, J.,Duan, Z.J., 2016. Functional and Structural Characterization of P[19] Rotavirus VP8* Interaction with Histo-blood Group Antigens. J Virol, 90, 9758-9765.

  • Tan, M., Hegde, R.S.,Jiang, X., 2004. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol, 78, 6233-6242.

  • Tan, M.,Jiang, X., 2005. Norovirus and its histo-blood group antigen receptors:an answer to a historical puzzle. Trends Microbiol, 13, 285-293.

  • Tan, M.,Jiang, X., 2011. Norovirus-host interaction:Multi-selections by human histo-blood group antigens. Trends in Microbiology, 19, 382-388.

  • Tan, M.,Jiang, X., 2012. Norovirus P particle:a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus. Nanomedicine (Lond), 7, 889-897.

  • Tan, M.,Jiang, X., 2014. Histo-blood group antigens:a common niche for norovirus and rotavirus. Expert Rev Mol Med, 16, e5.